597 related articles for article (PubMed ID: 31082387)
21. Group 2 innate lymphoid cells (ILC2s) are important in typical type 2 immune-mediated diseases and an essential therapeutic target.
Jin J; Sunusi S; Lu H
J Int Med Res; 2022 Jan; 50(1):3000605211053156. PubMed ID: 35048721
[TBL] [Abstract][Full Text] [Related]
22. Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps.
Poposki JA; Klingler AI; Tan BK; Soroosh P; Banie H; Lewis G; Hulse KE; Stevens WW; Peters AT; Grammer LC; Schleimer RP; Welch KC; Smith SS; Conley DB; Raviv JR; Karras JG; Akbari O; Kern RC; Kato A
Immun Inflamm Dis; 2017 Sep; 5(3):233-243. PubMed ID: 28474861
[TBL] [Abstract][Full Text] [Related]
23. Protein kinase Cθ controls type 2 innate lymphoid cell and T
Madouri F; Chenuet P; Beuraud C; Fauconnier L; Marchiol T; Rouxel N; Ledru A; Gallerand M; Lombardi V; Mascarell L; Marquant Q; Apetoh L; Erard F; Le Bert M; Trovero F; Quesniaux VFJ; Ryffel B; Togbe D
J Allergy Clin Immunol; 2017 May; 139(5):1650-1666. PubMed ID: 27746240
[TBL] [Abstract][Full Text] [Related]
24. Crocin Inhibits the Type 2 Inflammatory Response Produced by ILC2s in Eosinophilic Nasal Polyps.
Xiaodong X; Tao L; Jianmin L; Jing Z; Bing Z; Jintao D; Bachert C; Luo B
Am J Rhinol Allergy; 2023 Nov; 37(6):656-669. PubMed ID: 37424236
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms to Suppress ILC2-induced Airway Inflammation.
Kabata H; Moro K; Koyasu S; Fukunaga K; Asano K; Betsuyaku T
Ann Am Thorac Soc; 2016 Mar; 13 Suppl 1():S95. PubMed ID: 27027961
[TBL] [Abstract][Full Text] [Related]
26. Group 2 innate lymphoid cells (ILC2s): The spotlight in asthma pathogenesis and lung tissue injury.
Sadik S; Lu Y; Zhu S; Cai J; Mi LL
Allergol Immunopathol (Madr); 2021; 49(2):208-216. PubMed ID: 33641310
[TBL] [Abstract][Full Text] [Related]
27. Th9 and other IL-9-producing cells in allergic asthma.
Koch S; Sopel N; Finotto S
Semin Immunopathol; 2017 Jan; 39(1):55-68. PubMed ID: 27858144
[TBL] [Abstract][Full Text] [Related]
28. The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation.
Klose CSN; Mahlakõiv T; Moeller JB; Rankin LC; Flamar AL; Kabata H; Monticelli LA; Moriyama S; Putzel GG; Rakhilin N; Shen X; Kostenis E; König GM; Senda T; Carpenter D; Farber DL; Artis D
Nature; 2017 Sep; 549(7671):282-286. PubMed ID: 28869965
[TBL] [Abstract][Full Text] [Related]
29. ILC2 frequency and activity are inhibited by glucocorticoid treatment via STAT pathway in patients with asthma.
Yu QN; Guo YB; Li X; Li CL; Tan WP; Fan XL; Qin ZL; Chen D; Wen WP; Zheng SG; Fu QL
Allergy; 2018 Sep; 73(9):1860-1870. PubMed ID: 29542140
[TBL] [Abstract][Full Text] [Related]
30. Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia.
Ho J; Bailey M; Zaunders J; Mrad N; Sacks R; Sewell W; Harvey RJ
Clin Exp Allergy; 2015 Feb; 45(2):394-403. PubMed ID: 25429730
[TBL] [Abstract][Full Text] [Related]
31. Type 2 Innate Lymphoid Cells in Allergic Disease.
Lund S; Walford HH; Doherty TA
Curr Immunol Rev; 2013 Nov; 9(4):214-221. PubMed ID: 24876829
[TBL] [Abstract][Full Text] [Related]
32. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
[TBL] [Abstract][Full Text] [Related]
33. [Type 2 innate lymphoid cells and chronic rhinosinusitis].
Geng CL; Xing ZM
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 30(7):585-588. PubMed ID: 29871081
[TBL] [Abstract][Full Text] [Related]
34. Cytokine-induced endogenous production of prostaglandin D
Maric J; Ravindran A; Mazzurana L; Van Acker A; Rao A; Kokkinou E; Ekoff M; Thomas D; Fauland A; Nilsson G; Wheelock CE; Dahlén SE; Ferreirós N; Geisslinger G; Friberg D; Heinemann A; Konya V; Mjösberg J
J Allergy Clin Immunol; 2019 Jun; 143(6):2202-2214.e5. PubMed ID: 30578872
[TBL] [Abstract][Full Text] [Related]
35. Association between group 2 innate lymphoid cells enrichment, nasal polyps and allergy in chronic rhinosinusitis.
Miljkovic D; Bassiouni A; Cooksley C; Ou J; Hauben E; Wormald PJ; Vreugde S
Allergy; 2014 Sep; 69(9):1154-61. PubMed ID: 24924975
[TBL] [Abstract][Full Text] [Related]
36. T-bet inhibits innate lymphoid cell-mediated eosinophilic airway inflammation by suppressing IL-9 production.
Matsuki A; Takatori H; Makita S; Yokota M; Tamachi T; Suto A; Suzuki K; Hirose K; Nakajima H
J Allergy Clin Immunol; 2017 Apr; 139(4):1355-1367.e6. PubMed ID: 27670243
[TBL] [Abstract][Full Text] [Related]
37. IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs.
Bal SM; Bernink JH; Nagasawa M; Groot J; Shikhagaie MM; Golebski K; van Drunen CM; Lutter R; Jonkers RE; Hombrink P; Bruchard M; Villaudy J; Munneke JM; Fokkens W; Erjefält JS; Spits H; Ros XR
Nat Immunol; 2016 Jun; 17(6):636-45. PubMed ID: 27111145
[TBL] [Abstract][Full Text] [Related]
38. A Potential Role of Group 2 Innate Lymphoid Cells in Eosinophilic Chronic Rhinosinusitis With Nasal Polyps.
Li Y; Wang W; Ying S; Lan F; Zhang L
Allergy Asthma Immunol Res; 2021 May; 13(3):363-374. PubMed ID: 33733633
[TBL] [Abstract][Full Text] [Related]
39. Sex differences in group 2 innate lymphoid cell-dominant allergic airway inflammation.
Wang C; Xu ZB; Peng YQ; Zhang HY; Yu QN; Guo YB; Tan WP; Liu YL; Meng XC; Fang SB; Chen D; Fu QL
Mol Immunol; 2020 Dec; 128():89-97. PubMed ID: 33096416
[TBL] [Abstract][Full Text] [Related]
40. The Therapeutic Potential for Targeting Group 2 Innate Lymphoid Cells in Asthma.
Matsuyama T; Matsuyama H; Dotake Y; Takagi K; Machida K; Inoue H
Front Immunol; 2022; 13():930862. PubMed ID: 35911708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
